122 results
425
EX-2.1
THER
Theralink Technologies, Inc.
26 May 23
Business combination disclosure
5:14pm
Laws; and (b) any petroleum or petroleum-derived products, radon, radioactive materials or wastes, asbestos in any form, lead or lead-containing … materials, urea formaldehyde foam insulation, and polychlorinated biphenyls.
“Healthcare Action” has the meaning set forth in Section 4.15(c).
“Healthcare
425
EX-99.1
THER
Theralink Technologies, Inc.
26 May 23
Business combination disclosure
5:14pm
in the Registration Statement, the joint proxy statement/prospectus and other relevant materials to be filed with the SEC when they become available. Shareholders
425
6krbdr
26 May 23
Business combination disclosure
5:14pm
8-K
EX-99.1
b79p8zu
26 May 23
Theralink® Signs Definitive Merger Agreement to be Acquired by
5:11pm
8-K
0ptkx shltimqt88
26 May 23
Theralink® Signs Definitive Merger Agreement to be Acquired by
5:11pm
8-K
EX-2.1
u4judqe
26 May 23
Theralink® Signs Definitive Merger Agreement to be Acquired by
5:11pm
D
0qilxw7n192didh
14 Dec 22
$3.40 mm in debt / options, 12 investors
4:54pm
8-K
EX-10.1
f8jtebmqtp bm3myv4ma
8 Dec 22
Theralink® Technologies Appoints Seasoned Commercial Leader, Faith Zaslavsky, as President & Chief
7:23pm
8-K
EX-10.2
inppjxkjg3z5ksf4kspx
1 Dec 22
Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares
5:15pm
8-K
EX-10.1
51xy4gi3k0t5er1z fs
1 Dec 22
Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares
5:15pm
8-K
5zngdcse0d cv6zn
1 Dec 22
Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares
5:15pm
DEF 14C
uf9rdh26
2 Jun 22
Information statement
9:15am